Published in PLoS One on December 22, 2010
Royal jelly increases collagen production in rat skin after ovariectomy. J Med Food (2012) 0.94
Antidepressant-like activity of 10-hydroxy-trans-2-decenoic Acid, a unique unsaturated Fatty Acid of royal jelly, in stress-inducible depression-like mouse model. Evid Based Complement Alternat Med (2011) 0.87
Use of dicarboxylic acids in type 2 diabetes. Br J Clin Pharmacol (2013) 0.85
Proteomics analysis reveals protein expression differences for hypopharyngeal gland activity in the honeybee, Apis mellifera carnica Pollmann. BMC Genomics (2014) 0.78
Identification of a novel hypocholesterolemic protein, major royal jelly protein 1, derived from royal jelly. PLoS One (2014) 0.78
The Lyophilization Process Maintains the Chemical and Biological Characteristics of Royal Jelly. Evid Based Complement Alternat Med (2015) 0.77
Royal Jelly and its dual role in TNBS colitis in mice. ScientificWorldJournal (2015) 0.75
In Vitro Anti-Inflammatory Effects of Three Fatty Acids from Royal Jelly. Mediators Inflamm (2016) 0.75
Therapeutic Properties of Bioactive Compounds from Different Honeybee Products. Front Pharmacol (2017) 0.75
All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00
Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods (1986) 12.51
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (1986) 11.35
Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A (1996) 10.94
Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 9.09
CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem (2010) 8.79
Mechanisms of estrogen action. Physiol Rev (2001) 5.97
Estrogen receptors and human disease. J Clin Invest (2006) 4.91
Sequence and expression of human estrogen receptor complementary DNA. Science (1986) 4.36
Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem (2000) 3.34
Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem (2001) 3.24
Polyunsaturated fatty acids in lipid bilayers: intrinsic and environmental contributions to their unique physical properties. J Am Chem Soc (2002) 2.76
Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol (1998) 2.55
Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev (1993) 2.52
Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun (2001) 1.67
Mechanisms of estrogen signaling and gene expression via GPR30. Mol Cell Endocrinol (2009) 1.55
Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res (2002) 1.49
Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A. Oncogene (2005) 1.36
Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Cancer Res (2007) 1.35
Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha. J Biol Chem (2002) 1.35
The genome landscape of ERalpha- and ERbeta-binding DNA regions. Proc Natl Acad Sci U S A (2008) 1.27
Usefulness of the 5' region of the cDNA encoding acidic ribosomal phosphoprotein P0 conserved among rats, mice, and humans as a standard probe for gene expression analysis in different tissues and animal species. J Biochem Biophys Methods (2006) 1.13
Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells. Clin Cancer Res (2000) 1.11
Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. Proc Natl Acad Sci U S A (2004) 1.06
Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism. J Biomed Mater Res A (2006) 1.03
Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs. J Control Release (2004) 1.02
Royal jelly has estrogenic effects in vitro and in vivo. J Ethnopharmacol (2005) 0.98
Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity. Proteins (2009) 0.97
Estrogenic activities of Fatty acids and a sterol isolated from royal jelly. Evid Based Complement Alternat Med (2008) 0.96
Activity of 10-hydroxydecenoic acid from royal jelly against experimental leukaemia and ascitic tumours. Nature (1959) 0.96
Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4. Bone (1996) 0.94
Overview of in vitro tools to assess the estrogenic and antiestrogenic activity of phytoestrogens. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.93
The short-chain fatty acid methoxyacetic acid disrupts endogenous estrogen receptor-alpha-mediated signaling. Environ Health Perspect (2009) 0.92
Royal jelly stimulates bone formation: physiologic and nutrigenomic studies with mice and cell lines. Biosci Biotechnol Biochem (2006) 0.90
Binding of estrogen receptor alpha/beta heterodimers to chromatin in MCF-7 cells. J Mol Endocrinol (2009) 0.87
Chemistry and bioactivity of royal jelly from Greece. J Agric Food Chem (2005) 0.85
Selective activation of estrogen receptor-beta target genes by 3,3'-diindolylmethane. Endocrinology (2010) 0.84
Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines. J Biol Chem (1992) 0.83
Tumor treatment by sustained intratumoral release of 5-fluorouracil: effects of drug alone and in combined treatments. Int J Radiat Oncol Biol Phys (2002) 0.82
Identification of tamoxifen-induced coregulator interaction surfaces within the ligand-binding domain of estrogen receptors. Mol Cell Biol (2004) 0.81
Application of solid/liquid extraction for the gravimetric determination of lipids in royal jelly. J Agric Food Chem (2002) 0.81
Cytotoxicity testing of poly(anhydride-co-imides) for orthopedic applications. J Biomed Mater Res (1995) 0.78
Regulation of the action of steroid/thyroid hormone receptors by medium-chain fatty acids. J Biol Chem (1998) 0.78
Acteoside and martynoside exhibit estrogenic/antiestrogenic properties. J Steroid Biochem Mol Biol (2005) 0.78
Effects of aliphatic dioic acids and glycerol-1,2,3-tris(dodecanedioate) on D-glucose-stimulated insulin release in rat pancreatic islets. Br J Nutr (2000) 0.77
Optimized determination method for trans-10-hydroxy-2-decenoic acid content in royal jelly by high-performance liquid chromatography with an internal standard. J AOAC Int (2007) 0.76
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res (2002) 4.93
Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal (2010) 4.77
Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep (2009) 4.01
Genome-wide analysis of single nucleotide polymorphisms uncovers population structure in Northern Europe. PLoS One (2008) 3.09
Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics (2009) 2.67
Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci (2002) 2.51
Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. Mol Endocrinol (2003) 2.38
Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J (2002) 2.26
Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls. Metabolism (2005) 2.24
Screening for congenital hypothyroidism: the significance of threshold limit in false-negative results. J Clin Endocrinol Metab (2010) 2.20
Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation (2005) 2.15
A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J Allergy Clin Immunol (2004) 2.12
Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev (2005) 2.09
Metabolic consequences of stress during childhood and adolescence. Metabolism (2011) 2.04
Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am (2002) 2.02
Perceived Stress Scale: reliability and validity study in Greece. Int J Environ Res Public Health (2011) 1.99
Estrogen receptor beta: an overview and update. Nucl Recept Signal (2008) 1.97
Optimization of the CHARMM additive force field for DNA: Improved treatment of the BI/BII conformational equilibrium. J Chem Theory Comput (2012) 1.93
Puberty-related influences on brain development. Mol Cell Endocrinol (2006) 1.93
Impact of 2'-hydroxyl sampling on the conformational properties of RNA: update of the CHARMM all-atom additive force field for RNA. J Comput Chem (2011) 1.81
Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism (2011) 1.79
Pediatric stress: hormonal mediators and human development. Horm Res (2003) 1.79
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab (2005) 1.77
Increased vitamin D supplementation recommended during summer season in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle Eastern residents. Clin Endocrinol (Oxf) (2012) 1.77
Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med (2011) 1.76
Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol (2003) 1.74
CHRONIC INSOMNIA AND STRESS SYSTEM. Sleep Med Clin (2007) 1.72
The human glucocorticoid receptor: molecular basis of biologic function. Steroids (2009) 1.69
Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol (2007) 1.68
Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab (2003) 1.63
Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci (2006) 1.62
Molecular dynamics simulations of nucleic acid-protein complexes. Curr Opin Struct Biol (2008) 1.61
Mycoredoxin-1 is one of the missing links in the oxidative stress defence mechanism of Mycobacteria. Mol Microbiol (2012) 1.61
Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise. J Clin Endocrinol Metab (2004) 1.60
Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol Metab (2010) 1.60
Liver X receptor in cholesterol metabolism. J Endocrinol (2009) 1.59
Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. J Clin Endocrinol Metab (2002) 1.57
Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med (2002) 1.52
The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J Endocrinol (2011) 1.52
Molecular dynamics applied to nucleic acids. Acc Chem Res (2002) 1.52
Decreased plasma CXCL16/SR-PSOX concentration is associated with coronary artery disease. Atherosclerosis (2005) 1.52
Genome-wide identification of estrogen receptor alpha-binding sites in mouse liver. Mol Endocrinol (2007) 1.50
Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Ann N Y Acad Sci (2006) 1.50
The 'self-plagiarism' oxymoron: can one steal from oneself? Eur J Clin Invest (2012) 1.49
Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab (2002) 1.46
Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes (2012) 1.44
The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy. Nature (2013) 1.43
Intrinsic conformational energetics associated with the glycosyl torsion in DNA: a quantum mechanical study. Biophys J (2002) 1.40
Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab (2008) 1.40
Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells. Cancer Res (2009) 1.40
Retracted Chronic recurrent multifocal osteomyelitis with concomitant features of juvenile idiopathic arthritis. Case Rep Rheumatol (2011) 1.40
Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Oncogene (2003) 1.39
[The campaign for TBE vaccination of small children is unethical and incorrect]. Lakartidningen (2004) 1.39
G protein beta interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus. J Cell Biol (2005) 1.37
Genome wide analysis reveals association of a FTO gene variant with epigenetic changes. Genomics (2012) 1.36
Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol Endocrinol (2006) 1.36
Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med (2007) 1.36
Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Cancer Res (2007) 1.35
Elevated levels of growth-related hormones in autism and autism spectrum disorder. Clin Endocrinol (Oxf) (2007) 1.34
Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest (2009) 1.32
Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab (2010) 1.32
Leptin and hunger levels in young healthy adults after one night of sleep loss. J Sleep Res (2010) 1.31
Persistent insomnia: the role of objective short sleep duration and mental health. Sleep (2012) 1.31
Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5. Sci Signal (2009) 1.30
The transcription factor encyclopedia. Genome Biol (2012) 1.28
The genome landscape of ERalpha- and ERbeta-binding DNA regions. Proc Natl Acad Sci U S A (2008) 1.27
Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab (2007) 1.26
Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice. Proc Natl Acad Sci U S A (2013) 1.26
Beta-sitosterol exhibits anti-inflammatory activity in human aortic endothelial cells. Mol Nutr Food Res (2010) 1.25
Exercise and the stress system. Hormones (Athens) (2006) 1.24
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A (2005) 1.24
Mitochondria as key components of the stress response. Trends Endocrinol Metab (2007) 1.23
Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab (2002) 1.22
Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab (2008) 1.21
Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci (2009) 1.21
Children with classic congenital adrenal hyperplasia have decreased amygdala volume: potential prenatal and postnatal hormonal effects. J Clin Endocrinol Metab (2003) 1.21
Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? Stem Cells (2014) 1.21
Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1. Cancer Res (2010) 1.20
A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. J Clin Endocrinol Metab (2012) 1.20
Glucocorticoid and mineralocorticoid receptors and associated diseases. Essays Biochem (2004) 1.20
Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer (2007) 1.20
Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab (2004) 1.19
Sleep-disordered breathing in obese children is associated with prevalent excessive daytime sleepiness, inflammation, and metabolic abnormalities. J Clin Endocrinol Metab (2009) 1.18
Genome wide association study identifies KCNMA1 contributing to human obesity. BMC Med Genomics (2011) 1.18
The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J Clin Endocrinol Metab (2009) 1.17
Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS One (2011) 1.16
Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. J Clin Endocrinol Metab (2005) 1.15
Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovasc Diabetol (2012) 1.14
Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha. J Immunol (2002) 1.14
The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism. Mol Endocrinol (2004) 1.13
Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest. J Virol (2005) 1.13
A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J Clin Endocrinol Metab (2002) 1.13
Estrogen signaling via estrogen receptor {beta}. J Biol Chem (2010) 1.12